Eliem Therapeutics, Inc.
NASDAQ:ELYM
5.11 (USD) • At close October 2, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 93.112 | 43.585 | 46.922 | 20.487 | 21.223 |
| Short Term Investments
| 13.686 | 79.981 | 89.558 | 0 | 0 |
| Cash and Short Term Investments
| 106.798 | 123.566 | 136.48 | 20.487 | 21.223 |
| Net Receivables
| 2.024 | 6.492 | 0 | 0 | 0 |
| Inventory
| 0 | -6.492 | 4.397 | 0 | 0 |
| Other Current Assets
| 1.433 | 4.335 | 16.169 | 1.511 | 0.06 |
| Total Current Assets
| 110.255 | 134.393 | 148.252 | 21.998 | 21.283 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 0.199 | 0.471 | 0 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 24.919 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.015 | 0.128 | 0.07 | 2.633 | 0.112 |
| Total Non-Current Assets
| 0.214 | 0.599 | 24.989 | 2.633 | 0.112 |
| Total Assets
| 110.469 | 134.992 | 173.241 | 24.631 | 21.395 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 0.066 | 0.75 | 1.404 | 1.086 | 0.647 |
| Short Term Debt
| 0.668 | 0.6 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| -0.066 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 2.099 | 4.747 | 4.627 | 1.977 | 0.136 |
| Total Current Liabilities
| 2.833 | 6.097 | 6.031 | 3.063 | 0.783 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 0.03 | 0.36 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.007 | -0.18 | 0.007 | 0 | 0 |
| Total Non-Current Liabilities
| 0.037 | 0.18 | 0.007 | 0 | 0 |
| Total Liabilities
| 2.87 | 6.277 | 6.038 | 3.063 | 0.783 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 173.241 | 46.551 | 26.174 |
| Common Stock
| 0.003 | 0.003 | 0.003 | 0.001 | 0.001 |
| Retained Earnings
| -155.979 | -120.86 | -75.616 | -28.136 | -7.468 |
| Accumulated Other Comprehensive Income/Loss
| -0.002 | -0.358 | -0.123 | -0 | -0 |
| Other Total Stockholders Equity
| 263.577 | 249.93 | 242.939 | 3.152 | 1.905 |
| Total Shareholders Equity
| 107.599 | 128.715 | 167.203 | 21.568 | 20.612 |
| Total Equity
| 107.599 | 128.715 | 167.203 | 21.568 | 20.612 |
| Total Liabilities & Shareholders Equity
| 110.469 | 134.992 | 173.241 | 24.631 | 21.395 |